Distinguishing Detectable From Clinically Relevant Immunogenicity With Subcutaneous Infliximab
Min-Yuan Lu1,2, Yu-Ping Shu2, Rong Shi2
1Department of Anorectal Surgery, Fuzhou Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China.
United European Gastroenterology Journal
|June 2, 2026
Summary
No abstract available in PubMed .
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
